Prognostic factors in hepatocellular carcinoma

被引:0
作者
Chemello, Liliana [1 ]
Shukla, Pradeep Kumar [2 ]
Dallio, Marcello [3 ]
机构
[1] Univ Padua, Dept Med DIMED, Padua, Italy
[2] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN USA
[3] Univ Campania Luigi Vanvitelli, Dept Gastroenterol, Hepatol & Digest Endoscopy, Naples, Italy
关键词
HCC; tumor prognosis; hepatocellular carcinoma; immunotherapy; biomarkers;
D O I
10.3389/fmed.2023.1331207
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 4 条
[1]   Systemic treatment of hepatocellular carcinoma: An EASL position paper [J].
Bruix, Jordi ;
Chan, Stephen L. ;
Galle, Peter R. ;
Rimassa, Lorenza ;
Sangro, Bruno .
JOURNAL OF HEPATOLOGY, 2021, 75 (04) :960-974
[2]  
European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI [10.1016/j.ejca.2011.12.021, 10.1016/j.jhep.2011.12.001]
[3]   Hepatocellular carcinoma [J].
Forner, Alejandro ;
Llovet, Josep M. ;
Bruix, Jordi .
LANCET, 2012, 379 (9822) :1245-1255
[4]   The Role of Artificial Intelligence in the Detection and Implementation of Biomarkers for Hepatocellular Carcinoma: Outlook and Opportunities [J].
Mansur, Arian ;
Vrionis, Andrea ;
Charles, Jonathan P. ;
Hancel, Kayesha ;
Panagides, John C. ;
Moloudi, Farzad ;
Iqbal, Shams ;
Daye, Dania .
CANCERS, 2023, 15 (11)